Pelthos Therapeutics Inc. (PTHS) Revenue History
Annual and quarterly revenue from 2022 to present
PTHS Revenue Over Time (2022–2025)
PTHS Revenue Growth History
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $10.9M | — |
| Q4 2025 | $9.4M | — |
| Q3 2025 | $7.4M | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
PTHS Revenue Analysis (2022–2025)
Current Revenue & Growth
As of June 21, 2026, Pelthos Therapeutics Inc. (PTHS) generated trailing twelve-month (TTM) revenue of $27.7 million. The most recent quarter (Q1 2026) recorded $10.9 million in revenue, up 16.2% sequentially.
Historical Growth Trajectory
PTHS's historical revenue data shows various trends over time. Pelthos Therapeutics Inc.'s highest annual revenue of $16.8 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including COLL (+19.9% YoY), AVDL (+79.9% YoY), and SUPN (+16.3% YoY). Compare PTHS vs COLL →
PTHS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PTHSCurrent | $28M | - | - | -193.1% | |
 COLL | $781M | +19.9% | +20.3% | 24.0% | |
 AVDL | $169M | +79.9% | +23.4% | -25.1% | |
 SUPN | $719M | +16.3% | +6.7% | -5.1% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% |
PTHS Historical Revenue Data (2022–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $16.8M | - | $10.5M | 62.6% | $-32,430,000 | -193.1% |
| 2024 | $0 | - | $0 | - | $-7,571,449 | - |
| 2023 | $0 | - | $0 | - | $-6,862,284 | - |
| 2022 | $0 | - | $0 | - | $-2,318,159 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PTHS — Frequently Asked Questions
Quick answers to the most common questions about buying PTHS stock.
Is PTHS's revenue growth accelerating or slowing?
PTHS TTM revenue: $28M. YoY growth: N/A. 5-year CAGR: N/A.
What is PTHS's revenue history from 2022 to 2026?
Pelthos Therapeutics Inc. (PTHS) revenue history spans 2022 to 2026. TTM revenue as of 2026 is $28M, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is PTHS's long-term revenue growth rate (CAGR)?
Pelthos Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PTHS.
Why does PTHS's quarterly revenue fluctuate?
PTHS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Pelthos Therapeutics Inc.'s revenue data from 2022 to 2026 shows full historical quarterly detail on this page.
How is PTHS's revenue distributed by segment?
PTHS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does PTHS's revenue compare to industry peers?
Pelthos Therapeutics Inc. (PTHS) with TTM revenue of $28M and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.